Managers / Q4 2022 · view latest →
HERSHEY TRUST CO
CIK 0000908551 · 1 EAST CHOCOLATE AVENUE, SUITE 400, HERSHEY, PA, 17033 · 7175201100
Summary
Hershey Trust Co reported $13.5B in U.S.-listed holdings across 7 positions for Q4 2022.
The portfolio is heavily concentrated: HSYFB alone accounts for 99.8% of reported value.
Compared with Q3 2022, the fund opened 1 new position and exited 9.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 99.9% · $13.5B
- Other · 0.1% · $20M
- ADR · 0.0% · $114,709
Quarter-over-Quarter Changes full breakdown →
vs Q3 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| NU HOLDINGS LTD | NEW | +390.3K | 390.3K | +$2M | $2M |
| PDDADR PINDUODUO INC SPONSORED AD | SOLD OUT | −125.2K | 0 | −$8M | $0 |
| MFC ISHARES MSCI USA | SOLD OUT | −19.0K | 0 | −$2M | $0 |
| UBERUBER TECHNOLOGIES INC COM USD0 | SOLD OUT | −69.1K | 0 | −$2M | $0 |
| TDOCTELADOC HEALTH INC | SOLD OUT | −65.5K | 0 | −$2M | $0 |
| INARI MED INC COM | SOLD OUT | −8.6K | 0 | −$622,000 | $0 |
| CHINOOK THERAPEUTICS INC COM U | SOLD OUT | −7.4K | 0 | −$146,000 | $0 |
| ADR DADA NEXUS LTD ADS | SOLD OUT | −29.1K | 0 | −$138,000 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | HSYFBHERSHEY COMPANY CLASS Bhistory → | COM | 99.82% | $13.5B | 58.11M |
| 2 | MEITUAN DIANPING USD0.00001 | COM | 0.12% | $17M | 745.4K |
| 3 | ABNBAIRBNB INC CL A COM USD0.0001 | COM | 0.03% | $5M | 53.2K |
| 4 | NU HOLDINGS LTD | COM | 0.01% | $2M | 390.3K |
| 5 | CRISPR THERAPEUTICS AG COM CHF | COM | 0.01% | $1M | 33.8K |
| 6 | MSFTMICROSOFT CORP | COM | 0.00% | $544,871 | 2.3K |
| 7 | DIDIYADR DIDI GLOBAL INC SPON ADS | COM | 0.00% | $114,709 | 36.1K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $11.8B | 3 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $10.3B | 5 | Feb 10, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $10.6B | 8 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $9.4B | 6 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $9.7B | 6 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $9.6B | 5 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $10.9B | 2 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $10.4B | 3 | Aug 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $11.0B | 5 | May 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $10.6B | 3 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $11.4B | 7 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $14.2B | 7 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $14.6B | 6 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $13.5B | 7 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $12.8B | 15 | Nov 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $12.7B | 34 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $13.1B | 32 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $11.9B | 41 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $10.4B | 30 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $10.7B | 37 | Aug 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $9.7B | 35 | Apr 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $9.3B | 32 | Jan 21, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $8.7B | 21 | Oct 23, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $7.9B | 18 | Jul 22, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $8.1B | 28 | Apr 20, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $9.0B | 25 | Jan 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $9.5B | 21 | Oct 31, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $8.2B | 20 | Aug 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $7.4B | 20 | Apr 22, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $6.9B | 19 | Jan 16, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.